Cargando…
Colorectal Cancer Immunotherapy: Options and Strategies
Colorectal cancer is the third most common cancer in the world with increasing incidence and mortality rates globally. Standard treatments for colorectal cancer have always been surgery, chemotherapy and radiotherapy which may be used in combination to treat patients. However, these treatments have...
Autores principales: | Johdi, Nor Adzimah, Sukor, Nur Fazilah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530194/ https://www.ncbi.nlm.nih.gov/pubmed/33042104 http://dx.doi.org/10.3389/fimmu.2020.01624 |
Ejemplares similares
-
Cancer testis antigen PASD1 expression and immunogenicity in human colorectal cancer and polyps
por: SUKOR, Nur Fazilah, et al.
Publicado: (2022) -
Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps
por: Johdi, Nor Adzimah, et al.
Publicado: (2017) -
Immunomodulatory effects of extracellular vesicles in glioblastoma
por: Low, Johannes Jun Wei, et al.
Publicado: (2022) -
Mechanism and strategies of immunotherapy resistance in colorectal cancer
por: Shan, Jiqi, et al.
Publicado: (2022) -
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
por: Zeng, Jiayi, et al.
Publicado: (2021)